Login
Clinical Pharmacology & Therapeutics (2007) 82, 366–370. doi:10.1038/sj.clpt.6100363
C T Dollery1
1GlaxoSmithKline, Harlow, UK
Correspondence: CT Dollery, (colin.dollery@gsk.com)
Top